Pete Pharma & Fabrx Launch 3D Printing for US Pharmacies

In an industry-shaping collaboration, Pete Pharma has joined forces with Fabrx to introduce cutting-edge pharmaceutical 3D printing technology to the U.S. compounding pharmacy sector. This strategic partnership aims to revolutionize how personalized medicine is manufactured, paving the way for improved efficiency and customization in patient care.

Fabrx is known for its pioneering 3D printing platforms, widely utilized in hospitals and research institutions for producing personalized medicine and medical devices in small batches. Their M3DIMAKER 1 printer focuses on research applications, while the M3DIMAKER 2 boasts a multi-printhead for higher throughput, catering to both human and veterinary medicine. Through this partnership, Pete Pharma seeks to enhance workflow efficiency in compounding pharmacies, automating tedious processes and boosting medication personalization in niche areas like pediatrics and lifestyle therapeutics. With a “pharmacy-first” business model, Pete Pharma aims to cater to independent pharmacies by minimizing labor and waste.